Twan Lammers

Active 2005–2026

166
Papers
27,854
Citations
89
h-index
161
i10-index

Citations

Citations per year for Twan Lammers1993: 1 citations1997: 1 citations2006: 3 citations2007: 2 citations2008: 22 citations2009: 45 citations2010: 56 citations2011: 74 citations2012: 96 citations2013: 112 citations2014: 182 citations2015: 185 citations2016: 233 citations2017: 244 citations2018: 320 citations2019: 880 citations2020: 1,319 citations2021: 1,453 citations2022: 1,271 citations2023: 1,092 citations2024: 1,655 citations2025: 1,081 citations2026: 29 citations1994–1996: no citations, so these years are not shown1998–2005: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 3,344 citing papers, 26% of this breakdownUnited States: 1,925 citing papers, 15% of this breakdownGermany: 743 citing papers, 5.8% of this breakdownIndia: 652 citing papers, 5.1% of this breakdownUnited Kingdom: 426 citing papers, 3.3% of this breakdownNetherlands: 384 citing papers, 3% of this breakdownItaly: 381 citing papers, 3% of this breakdownFrance: 325 citing papers, 2.5% of this breakdownSouth Korea: 315 citing papers, 2.5% of this breakdownIran: 311 citing papers, 2.4% of this breakdownAustralia: 289 citing papers, 2.2% of this breakdownSpain: 274 citing papers, 2.1% of this breakdown
0%26%Other 27.1%

Fields

  • Medicine26.6%
  • Materials Science21.9%
  • Engineering19%
  • Biochemistry, Genetics and Molecular Biology18.5%
  • Immunology and Microbiology5.7%
  • Pharmacology, Toxicology and Pharmaceutics3%
  • Other5.3%

Topics

  • Nanoparticle-Based Drug Delivery10.2%
  • Nanoplatforms for cancer theranostics9.1%
  • RNA Interference and Gene Delivery5.2%
  • Advanced biosensing and bioanalysis techniques3.2%
  • Immunotherapy and Immune Responses2.2%
  • Advanced Drug Delivery Systems1.9%
  • Other68.2%

Coauthors

All papers

Open in search
  1. Smart cancer nanomedicine

    Authors: , , , , , - Nature Nanotechnology 2019 cited by 1,196

  2. The EPR effect and beyond: Strategies to improve tumor targeting and cancer nanomedicine treatment efficacy

    Authors: , , , - Theranostics 2020 cited by 830

  3. Integrating Artificial Intelligence and Nanotechnology for Precision Cancer Medicine

    Authors: , , , , , , , , - Advanced Materials 2019 cited by 475

  4. Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications

    Authors: , , , , , , - Advanced Drug Delivery Reviews 2019 cited by 1,139

  5. Cancer nanomedicine

    Authors: , , , - Nature reviews. Cancer 2022 cited by 381

  6. Tumor targeting via EPR: Strategies to enhance patient responses

    Authors: , , , , , , - Advanced Drug Delivery Reviews 2018 cited by 1,223

  7. Cancer-associated fibroblasts: Origin, function, imaging, and therapeutic targeting

    Authors: , , , , , , - Advanced Drug Delivery Reviews 2022 cited by 179

  8. Challenges and strategies in anti-cancer nanomedicine development: An industry perspective

    Authors: , , , , , - Advanced Drug Delivery Reviews 2016 cited by 1,156

  9. Combining Nanomedicine and Immunotherapy

    Authors: , - Accounts of Chemical Research 2019 cited by 456

  10. Iron metabolism: pathophysiology and pharmacology

    Authors: , , , , , - Trends in Pharmacological Sciences 2021 cited by 284

  11. Challenges in nanomedicine clinical translation

    Authors: , - Drug Delivery and Translational Research 2020 cited by 347

  12. Sublethal necroptosis signaling promotes inflammation and liver cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Josep M. Llovet, Ralf Weiskirchen, Jakob Nikolas Kather, Patrick Starlinger, Michael Trauner, Mark Luedde, Lara R. Heij, Ulf P. Neumann, Verena Keitel, Johannes G. Bode, Rebekka K. Schneider, Frank Tacke, Bodo Levkau, Twan Lammers, Georg Fluegen, Theodore Alexandrov, Amy Collins, Glyn Nelson, Fiona Oakley, Derek A. Mann, Christoph Roderburg, Thomas Longerich, Achim Weber, Augusto Villanueva, André L. Samson, James M. Murphy, Rafael Kramann, Fabian Geisler, Ivan G. Costa, Jan G. Hengstler, Mathias Heikenwälder, Tom Luedde - Immunity 2023 cited by 133

  13. Nanomedicine Tumor Targeting

    Authors: - Advanced Materials 2024 cited by 226

  14. A translational framework to DELIVER nanomedicines to the clinic

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature Nanotechnology 2024 cited by 219

  15. PLGA-Based Nanoparticles in Cancer Treatment

    Authors: , , , , , , , - Frontiers in Pharmacology 2018 cited by 588

  16. Motion model ultrasound localization microscopy for preclinical and clinical multiparametric tumor characterization

    Authors: , , , , , , , , , , - Nature Communications 2018 cited by 286

  17. From structural design to delivery: mRNA therapeutics for cancer immunotherapy

    Authors: , , , , , , , , , , , , , , , , , , , - Exploration 2023 cited by 105

  18. Metallodrugs in cancer nanomedicine

    Authors: , , , , , , , , , - Chemical Society Reviews 2022 cited by 235

  19. Toxicity of metal–organic framework nanoparticles: from essential analyses to potential applications

    Authors: , , , , , , , , - Chemical Society Reviews 2022 cited by 391

  20. Targeting iron metabolism in drug discovery and delivery

    Authors: , , - Nature Reviews Drug Discovery 2017 cited by 359

  21. Drug Targeting to Tumors: Principles, Pitfalls and (Pre-) Clinical Progress

    Authors: , , , - Journal of Controlled Release 2011 cited by 1,288

  22. 3D‐Bioprinted Mini‐Brain: A Glioblastoma Model to Study Cellular Interactions and Therapeutics

    Authors: , , , , , - Advanced Materials 2019 cited by 307

  23. Clinically established biodegradable long acting injectables: An industry perspective

    Authors: , , , , , , , , , , , - Advanced Drug Delivery Reviews 2020 cited by 151

  24. Nanoparticles for Cancer Diagnosis, Radionuclide Therapy and Theranostics

    Authors: , - ACS Nano 2021 cited by 104